PDB Short entry for 2XRG HEADER HYDROLASE 14-SEP-10 2XRG TITLE CRYSTAL STRUCTURE OF AUTOTAXIN (ENPP2) IN COMPLEX WITH THE HA155 TITLE 2 BORONIC ACID INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE FAMILY COMPND 3 MEMBER 2; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: RESIDUES 1-862; COMPND 6 SYNONYM: AUTOTAXIN ENPP2, EXTRACELLULAR LYSOPHOSPHOLIPASE D, LYSOPLD, COMPND 7 AUTOTAXIN, E-NPP 2; COMPND 8 EC: 3.1.4.39; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: FLIPIN; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS HYDROLASE, LYSOPHOSPHATIDIC ACID, LPA, LYSOPHOSPHATIDYLCHOLINE, LPC, KEYWDS 2 SOMATOMEDIN, METASTASIS, NEUROPATHIC PAIN, VASCULAR DEVELOPMENT, KEYWDS 3 NEURAL DEVELOPMENT EXPDTA X-RAY DIFFRACTION AUTHOR J.HAUSMANN,H.M.H.G.ALBERS,A.PERRAKIS REVDAT 4 20-DEC-23 2XRG 1 HETSYN REVDAT 3 29-JUL-20 2XRG 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 16-FEB-11 2XRG 1 JRNL REVDAT 1 19-JAN-11 2XRG 0 JRNL AUTH J.HAUSMANN,S.KAMTEKAR,E.CHRISTODOULOU,J.E.DAY,T.WU, JRNL AUTH 2 Z.FULKERSON,H.M.H.G.ALBERS,L.A.VAN MEETEREN,A.J.HOUBEN, JRNL AUTH 3 L.VAN ZEIJL,S.JANSEN,M.ANDRIES,T.HALL,L.E.PEGG,T.E.BENSON, JRNL AUTH 4 M.KASIEM,K.HARLOS,C.W.KOOI,S.S.SMYTH,H.OVAA,M.BOLLEN, JRNL AUTH 5 A.J.MORRIS,W.H.MOOLENAAR,A.PERRAKIS JRNL TITL STRUCTURAL BASIS OF SUBSTRATE DISCRIMINATION AND INTEGRIN JRNL TITL 2 BINDING BY AUTOTAXIN. JRNL REF NAT.STRUCT.MOL.BIOL. V. 18 198 2011 JRNL REFN ISSN 1545-9993 JRNL PMID 21240271 JRNL DOI 10.1038/NSMB.1980 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.8.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 15034 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 760 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.42 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2546 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2448 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2406 REMARK 3 BIN R VALUE (WORKING SET) : 0.2425 REMARK 3 BIN FREE R VALUE : 0.2854 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 140 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6116 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 11 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 97.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 15.67340 REMARK 3 B22 (A**2) : -13.16240 REMARK 3 B33 (A**2) : -2.51100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.578 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.894 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.822 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6382 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8675 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2142 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 145 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 926 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6346 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 1 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 801 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6053 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.93 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.75 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.28 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (A56-A395,A402-A457, A470-A556, A563-A569, A591 REMARK 3 -A858) REMARK 3 ORIGIN FOR THE GROUP (A): -27.4669 -0.6466 -9.6652 REMARK 3 T TENSOR REMARK 3 T11: -0.1535 T22: -0.2961 REMARK 3 T33: -0.0081 T12: -0.0203 REMARK 3 T13: 0.0171 T23: 0.0298 REMARK 3 L TENSOR REMARK 3 L11: 0.9962 L22: 0.9950 REMARK 3 L33: 2.2944 L12: -0.4932 REMARK 3 L13: -0.0273 L23: -0.5209 REMARK 3 S TENSOR REMARK 3 S11: -0.0555 S12: -0.0954 S13: -0.2078 REMARK 3 S21: 0.0849 S22: 0.0431 S23: 0.2056 REMARK 3 S31: -0.0328 S32: 0.0446 S33: 0.0124 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2XRG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1290045386. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-FEB-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.283 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15159 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.57000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2XR9 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.99750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.33600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.10200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 76.33600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.99750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.10200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 410 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ARG A 3 REMARK 465 GLN A 4 REMARK 465 GLY A 5 REMARK 465 CYS A 6 REMARK 465 LEU A 7 REMARK 465 GLY A 8 REMARK 465 SER A 9 REMARK 465 PHE A 10 REMARK 465 GLN A 11 REMARK 465 VAL A 12 REMARK 465 ILE A 13 REMARK 465 SER A 14 REMARK 465 LEU A 15 REMARK 465 PHE A 16 REMARK 465 THR A 17 REMARK 465 PHE A 18 REMARK 465 ALA A 19 REMARK 465 ILE A 20 REMARK 465 SER A 21 REMARK 465 VAL A 22 REMARK 465 ASN A 23 REMARK 465 ILE A 24 REMARK 465 CYS A 25 REMARK 465 LEU A 26 REMARK 465 GLY A 27 REMARK 465 PHE A 28 REMARK 465 THR A 29 REMARK 465 ALA A 30 REMARK 465 SER A 31 REMARK 465 ARG A 32 REMARK 465 ILE A 33 REMARK 465 LYS A 34 REMARK 465 ARG A 35 REMARK 465 ALA A 36 REMARK 465 GLU A 37 REMARK 465 TRP A 38 REMARK 465 ASP A 39 REMARK 465 GLU A 40 REMARK 465 GLY A 41 REMARK 465 PRO A 42 REMARK 465 PRO A 43 REMARK 465 THR A 44 REMARK 465 VAL A 45 REMARK 465 LEU A 46 REMARK 465 SER A 47 REMARK 465 ASP A 48 REMARK 465 SER A 49 REMARK 465 PRO A 50 REMARK 465 TRP A 51 REMARK 465 THR A 52 REMARK 465 ASN A 53 REMARK 465 THR A 54 REMARK 465 SER A 55 REMARK 465 SER A 396 REMARK 465 ILE A 397 REMARK 465 ASN A 398 REMARK 465 ASN A 399 REMARK 465 SER A 400 REMARK 465 LYS A 401 REMARK 465 LEU A 458 REMARK 465 ASP A 459 REMARK 465 VAL A 460 REMARK 465 TYR A 461 REMARK 465 LYS A 462 REMARK 465 LYS A 463 REMARK 465 PRO A 464 REMARK 465 SER A 465 REMARK 465 GLY A 466 REMARK 465 LYS A 467 REMARK 465 CYS A 468 REMARK 465 PHE A 469 REMARK 465 TYR A 557 REMARK 465 LEU A 558 REMARK 465 GLN A 559 REMARK 465 SER A 560 REMARK 465 GLU A 561 REMARK 465 PHE A 562 REMARK 465 ASP A 570 REMARK 465 LYS A 571 REMARK 465 VAL A 572 REMARK 465 GLU A 573 REMARK 465 PRO A 574 REMARK 465 LYS A 575 REMARK 465 ASN A 576 REMARK 465 LYS A 577 REMARK 465 LEU A 578 REMARK 465 GLU A 579 REMARK 465 GLU A 580 REMARK 465 LEU A 581 REMARK 465 ASN A 582 REMARK 465 LYS A 583 REMARK 465 ARG A 584 REMARK 465 LEU A 585 REMARK 465 HIS A 586 REMARK 465 THR A 587 REMARK 465 LYS A 588 REMARK 465 GLY A 589 REMARK 465 SER A 590 REMARK 465 GLU A 859 REMARK 465 SER A 860 REMARK 465 GLU A 861 REMARK 465 ILE A 862 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 72 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 97 122.84 -35.43 REMARK 500 GLU A 113 40.43 -80.28 REMARK 500 ALA A 116 -70.17 -66.22 REMARK 500 TYR A 375 -58.84 -127.84 REMARK 500 VAL A 379 -31.50 66.63 REMARK 500 CYS A 413 59.90 25.82 REMARK 500 GLN A 418 129.44 -35.29 REMARK 500 ALA A 435 -57.02 -157.12 REMARK 500 ASN A 436 82.28 -65.32 REMARK 500 ASN A 437 138.91 -175.47 REMARK 500 ARG A 450 -2.01 79.09 REMARK 500 PHE A 476 -169.08 -72.20 REMARK 500 LEU A 564 63.10 -106.60 REMARK 500 ASN A 728 64.37 60.85 REMARK 500 GLU A 757 105.26 -27.29 REMARK 500 ASN A 801 51.61 -106.08 REMARK 500 HIS A 822 35.32 -96.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 HA155 INHIBITOR (SWH): CO-CRYSTALLIZATION REMARK 600 IODIDE ION (IOD): FROM CRYSTALLIZATION BUFFER REMARK 600 CALCIUM ION (CA): IN ANALOGY WITH NATIVE REMARK 600 ZINC ION (ZN): IN ANALOGY WITH NATIVE REMARK 600 ALPHA-D-MANNOSE (MAN): GLYCOSYLATION REMARK 600 N-ACETYL-D-GLUCOSAMINE (NAG): GLYCOSYLATION REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1864 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 171 OD1 REMARK 620 2 THR A 209 OG1 128.7 REMARK 620 3 ASP A 358 OD2 91.2 119.8 REMARK 620 4 HIS A 359 NE2 104.5 112.2 93.8 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1863 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 311 OD1 REMARK 620 2 HIS A 315 NE2 98.9 REMARK 620 3 HIS A 474 NE2 120.8 85.4 REMARK 620 4 SWH A1862 O28 81.4 174.9 90.0 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A1865 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 739 OD1 REMARK 620 2 ASN A 741 OD1 82.0 REMARK 620 3 ASP A 743 OD1 75.4 81.3 REMARK 620 4 LEU A 745 O 73.8 154.8 85.8 REMARK 620 5 ASP A 747 OD1 82.9 88.8 157.2 95.0 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2XR9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AUTOTAXIN (ENPP2) DBREF 2XRG A 1 862 UNP Q64610 ENPP2_RAT 1 862 SEQADV 2XRG ALA A 410 UNP Q64610 ASN 410 ENGINEERED MUTATION SEQADV 2XRG THR A 591 UNP Q64610 ARG 591 CONFLICT SEQADV 2XRG GLU A 592 UNP Q64610 LYS 592 CONFLICT SEQRES 1 A 862 MET ALA ARG GLN GLY CYS LEU GLY SER PHE GLN VAL ILE SEQRES 2 A 862 SER LEU PHE THR PHE ALA ILE SER VAL ASN ILE CYS LEU SEQRES 3 A 862 GLY PHE THR ALA SER ARG ILE LYS ARG ALA GLU TRP ASP SEQRES 4 A 862 GLU GLY PRO PRO THR VAL LEU SER ASP SER PRO TRP THR SEQRES 5 A 862 ASN THR SER GLY SER CYS LYS GLY ARG CYS PHE GLU LEU SEQRES 6 A 862 GLN GLU VAL GLY PRO PRO ASP CYS ARG CYS ASP ASN LEU SEQRES 7 A 862 CYS LYS SER TYR SER SER CYS CYS HIS ASP PHE ASP GLU SEQRES 8 A 862 LEU CYS LEU LYS THR ALA ARG GLY TRP GLU CYS THR LYS SEQRES 9 A 862 ASP ARG CYS GLY GLU VAL ARG ASN GLU GLU ASN ALA CYS SEQRES 10 A 862 HIS CYS SER GLU ASP CYS LEU SER ARG GLY ASP CYS CYS SEQRES 11 A 862 THR ASN TYR GLN VAL VAL CYS LYS GLY GLU SER HIS TRP SEQRES 12 A 862 VAL ASP ASP ASP CYS GLU GLU ILE LYS VAL PRO GLU CYS SEQRES 13 A 862 PRO ALA GLY PHE VAL ARG PRO PRO LEU ILE ILE PHE SER SEQRES 14 A 862 VAL ASP GLY PHE ARG ALA SER TYR MET LYS LYS GLY SER SEQRES 15 A 862 LYS VAL MET PRO ASN ILE GLU LYS LEU ARG SER CYS GLY SEQRES 16 A 862 THR HIS ALA PRO TYR MET ARG PRO VAL TYR PRO THR LYS SEQRES 17 A 862 THR PHE PRO ASN LEU TYR THR LEU ALA THR GLY LEU TYR SEQRES 18 A 862 PRO GLU SER HIS GLY ILE VAL GLY ASN SER MET TYR ASP SEQRES 19 A 862 PRO VAL PHE ASP ALA SER PHE HIS LEU ARG GLY ARG GLU SEQRES 20 A 862 LYS PHE ASN HIS ARG TRP TRP GLY GLY GLN PRO LEU TRP SEQRES 21 A 862 ILE THR ALA THR LYS GLN GLY VAL ARG ALA GLY THR PHE SEQRES 22 A 862 PHE TRP SER VAL SER ILE PRO HIS GLU ARG ARG ILE LEU SEQRES 23 A 862 THR ILE LEU GLN TRP LEU SER LEU PRO ASP ASN GLU ARG SEQRES 24 A 862 PRO SER VAL TYR ALA PHE TYR SER GLU GLN PRO ASP PHE SEQRES 25 A 862 SER GLY HIS LYS TYR GLY PRO PHE GLY PRO GLU MET THR SEQRES 26 A 862 ASN PRO LEU ARG GLU ILE ASP LYS THR VAL GLY GLN LEU SEQRES 27 A 862 MET ASP GLY LEU LYS GLN LEU ARG LEU HIS ARG CYS VAL SEQRES 28 A 862 ASN VAL ILE PHE VAL GLY ASP HIS GLY MET GLU ASP VAL SEQRES 29 A 862 THR CYS ASP ARG THR GLU PHE LEU SER ASN TYR LEU THR SEQRES 30 A 862 ASN VAL ASP ASP ILE THR LEU VAL PRO GLY THR LEU GLY SEQRES 31 A 862 ARG ILE ARG ALA LYS SER ILE ASN ASN SER LYS TYR ASP SEQRES 32 A 862 PRO LYS THR ILE ILE ALA ALA LEU THR CYS LYS LYS PRO SEQRES 33 A 862 ASP GLN HIS PHE LYS PRO TYR MET LYS GLN HIS LEU PRO SEQRES 34 A 862 LYS ARG LEU HIS TYR ALA ASN ASN ARG ARG ILE GLU ASP SEQRES 35 A 862 ILE HIS LEU LEU VAL ASP ARG ARG TRP HIS VAL ALA ARG SEQRES 36 A 862 LYS PRO LEU ASP VAL TYR LYS LYS PRO SER GLY LYS CYS SEQRES 37 A 862 PHE PHE GLN GLY ASP HIS GLY PHE ASP ASN LYS VAL ASN SEQRES 38 A 862 SER MET GLN THR VAL PHE VAL GLY TYR GLY PRO THR PHE SEQRES 39 A 862 LYS TYR ARG THR LYS VAL PRO PRO PHE GLU ASN ILE GLU SEQRES 40 A 862 LEU TYR ASN VAL MET CYS ASP LEU LEU GLY LEU LYS PRO SEQRES 41 A 862 ALA PRO ASN ASN GLY THR HIS GLY SER LEU ASN HIS LEU SEQRES 42 A 862 LEU ARG THR ASN THR PHE ARG PRO THR MET PRO ASP GLU SEQRES 43 A 862 VAL SER ARG PRO ASN TYR PRO GLY ILE MET TYR LEU GLN SEQRES 44 A 862 SER GLU PHE ASP LEU GLY CYS THR CYS ASP ASP LYS VAL SEQRES 45 A 862 GLU PRO LYS ASN LYS LEU GLU GLU LEU ASN LYS ARG LEU SEQRES 46 A 862 HIS THR LYS GLY SER THR GLU GLU ARG HIS LEU LEU TYR SEQRES 47 A 862 GLY ARG PRO ALA VAL LEU TYR ARG THR SER TYR ASP ILE SEQRES 48 A 862 LEU TYR HIS THR ASP PHE GLU SER GLY TYR SER GLU ILE SEQRES 49 A 862 PHE LEU MET PRO LEU TRP THR SER TYR THR ILE SER LYS SEQRES 50 A 862 GLN ALA GLU VAL SER SER ILE PRO GLU HIS LEU THR ASN SEQRES 51 A 862 CYS VAL ARG PRO ASP VAL ARG VAL SER PRO GLY PHE SER SEQRES 52 A 862 GLN ASN CYS LEU ALA TYR LYS ASN ASP LYS GLN MET SER SEQRES 53 A 862 TYR GLY PHE LEU PHE PRO PRO TYR LEU SER SER SER PRO SEQRES 54 A 862 GLU ALA LYS TYR ASP ALA PHE LEU VAL THR ASN MET VAL SEQRES 55 A 862 PRO MET TYR PRO ALA PHE LYS ARG VAL TRP ALA TYR PHE SEQRES 56 A 862 GLN ARG VAL LEU VAL LYS LYS TYR ALA SER GLU ARG ASN SEQRES 57 A 862 GLY VAL ASN VAL ILE SER GLY PRO ILE PHE ASP TYR ASN SEQRES 58 A 862 TYR ASP GLY LEU ARG ASP THR GLU ASP GLU ILE LYS GLN SEQRES 59 A 862 TYR VAL GLU GLY SER SER ILE PRO VAL PRO THR HIS TYR SEQRES 60 A 862 TYR SER ILE ILE THR SER CYS LEU ASP PHE THR GLN PRO SEQRES 61 A 862 ALA ASP LYS CYS ASP GLY PRO LEU SER VAL SER SER PHE SEQRES 62 A 862 ILE LEU PRO HIS ARG PRO ASP ASN ASP GLU SER CYS ASN SEQRES 63 A 862 SER SER GLU ASP GLU SER LYS TRP VAL GLU GLU LEU MET SEQRES 64 A 862 LYS MET HIS THR ALA ARG VAL ARG ASP ILE GLU HIS LEU SEQRES 65 A 862 THR GLY LEU ASP PHE TYR ARG LYS THR SER ARG SER TYR SEQRES 66 A 862 SER GLU ILE LEU THR LEU LYS THR TYR LEU HIS THR TYR SEQRES 67 A 862 GLU SER GLU ILE MODRES 2XRG ASN A 524 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET SWH A1862 33 HET ZN A1863 1 HET ZN A1864 1 HET CA A1865 1 HET IOD A1866 1 HET IOD A1867 1 HET IOD A1868 1 HET IOD A1869 1 HET IOD A1870 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM SWH {4-[(4-{(Z)-[3-(4-FLUOROBENZYL)-2,4-DIOXO-1,3- HETNAM 2 SWH THIAZOLIDIN-5-YLIDENE]METHYL}PHENOXY) HETNAM 3 SWH METHYL]PHENYL}(TRIHYDROXY)BORATE(1-) HETNAM ZN ZINC ION HETNAM CA CALCIUM ION HETNAM IOD IODIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN SWH HA155 INHIBITOR FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 2 BMA C6 H12 O6 FORMUL 3 SWH C24 H20 B F N O6 S 1- FORMUL 4 ZN 2(ZN 2+) FORMUL 6 CA CA 2+ FORMUL 7 IOD 5(I 1-) FORMUL 12 HOH *11(H2 O) HELIX 1 1 LEU A 78 SER A 83 1 6 HELIX 2 2 ASP A 88 CYS A 93 1 6 HELIX 3 3 ASP A 122 GLY A 127 1 6 HELIX 4 4 ASN A 132 CYS A 137 1 6 HELIX 5 5 HIS A 142 ASP A 146 5 5 HELIX 6 6 ARG A 174 LYS A 180 5 7 HELIX 7 7 MET A 185 GLY A 195 1 11 HELIX 8 8 LYS A 208 GLY A 219 1 12 HELIX 9 9 TYR A 221 GLY A 226 1 6 HELIX 10 10 ARG A 246 ASN A 250 5 5 HELIX 11 11 PRO A 258 LYS A 265 1 8 HELIX 12 12 PRO A 280 LEU A 292 1 13 HELIX 13 13 ASP A 311 GLY A 318 1 8 HELIX 14 14 GLY A 321 GLU A 323 5 3 HELIX 15 15 MET A 324 LEU A 345 1 22 HELIX 16 16 SER A 373 TYR A 375 5 3 HELIX 17 17 ASP A 403 ALA A 410 1 8 HELIX 18 18 GLN A 426 LEU A 428 5 3 HELIX 19 19 PRO A 429 HIS A 433 5 5 HELIX 20 20 VAL A 480 GLN A 484 5 5 HELIX 21 21 GLU A 507 GLY A 517 1 11 HELIX 22 22 LEU A 530 LEU A 533 5 4 HELIX 23 23 SER A 659 SER A 663 5 5 HELIX 24 24 ASN A 665 ASP A 672 1 8 HELIX 25 25 ALA A 691 PHE A 696 1 6 HELIX 26 26 TYR A 705 VAL A 718 1 14 HELIX 27 27 VAL A 718 ASN A 728 1 11 HELIX 28 28 THR A 748 ILE A 752 5 5 HELIX 29 29 PRO A 780 CYS A 784 5 5 HELIX 30 30 ASP A 810 LYS A 813 5 4 HELIX 31 31 TRP A 814 HIS A 822 1 9 HELIX 32 32 ARG A 825 GLY A 834 1 10 HELIX 33 33 SER A 844 LYS A 852 1 9 SHEET 1 AA 5 THR A 196 HIS A 197 0 SHEET 2 AA 5 PHE A 487 TYR A 490 -1 O GLY A 489 N THR A 196 SHEET 3 AA 5 ASN A 352 GLY A 357 -1 O VAL A 353 N TYR A 490 SHEET 4 AA 5 LEU A 165 ASP A 171 1 O ILE A 166 N ILE A 354 SHEET 5 AA 5 VAL A 302 PRO A 310 1 O TYR A 303 N ILE A 167 SHEET 1 AB 2 MET A 201 ARG A 202 0 SHEET 2 AB 2 PHE A 503 GLU A 504 1 O PHE A 503 N ARG A 202 SHEET 1 AC 2 MET A 232 ASP A 234 0 SHEET 2 AC 2 ALA A 239 PHE A 241 -1 O ALA A 239 N ASP A 234 SHEET 1 AD 2 GLU A 362 ASP A 363 0 SHEET 2 AD 2 GLY A 472 ASP A 473 -1 O ASP A 473 N GLU A 362 SHEET 1 AE 2 THR A 369 PHE A 371 0 SHEET 2 AE 2 HIS A 452 ALA A 454 1 O HIS A 452 N GLU A 370 SHEET 1 AF 4 ILE A 382 VAL A 385 0 SHEET 2 AF 4 LEU A 389 ALA A 394 -1 O ARG A 391 N VAL A 385 SHEET 3 AF 4 ILE A 443 VAL A 447 -1 O ILE A 443 N ILE A 392 SHEET 4 AF 4 PHE A 420 MET A 424 -1 O LYS A 421 N LEU A 446 SHEET 1 AG 2 ALA A 602 VAL A 603 0 SHEET 2 AG 2 LEU A 835 ASP A 836 -1 O ASP A 836 N ALA A 602 SHEET 1 AH 7 TYR A 609 TYR A 613 0 SHEET 2 AH 7 GLU A 618 SER A 622 -1 O SER A 619 N LEU A 612 SHEET 3 AH 7 MET A 627 ILE A 635 -1 O MET A 627 N SER A 622 SHEET 4 AH 7 VAL A 730 ILE A 737 -1 O VAL A 730 N ILE A 635 SHEET 5 AH 7 HIS A 766 CYS A 774 -1 O HIS A 766 N ILE A 737 SHEET 6 AH 7 LEU A 788 PRO A 796 -1 O SER A 789 N SER A 773 SHEET 7 AH 7 THR A 823 ALA A 824 -1 O ALA A 824 N SER A 792 SHEET 1 AI 2 SER A 676 PHE A 679 0 SHEET 2 AI 2 MET A 701 MET A 704 -1 O VAL A 702 N GLY A 678 SSBOND 1 CYS A 58 CYS A 75 1555 1555 2.03 SSBOND 2 CYS A 62 CYS A 93 1555 1555 2.04 SSBOND 3 CYS A 73 CYS A 86 1555 1555 2.03 SSBOND 4 CYS A 79 CYS A 85 1555 1555 2.04 SSBOND 5 CYS A 102 CYS A 119 1555 1555 2.03 SSBOND 6 CYS A 107 CYS A 137 1555 1555 2.03 SSBOND 7 CYS A 117 CYS A 130 1555 1555 2.03 SSBOND 8 CYS A 123 CYS A 129 1555 1555 2.03 SSBOND 9 CYS A 148 CYS A 194 1555 1555 2.03 SSBOND 10 CYS A 156 CYS A 350 1555 1555 2.03 SSBOND 11 CYS A 413 CYS A 805 1555 1555 2.04 SSBOND 12 CYS A 566 CYS A 666 1555 1555 2.03 SSBOND 13 CYS A 568 CYS A 651 1555 1555 2.04 SSBOND 14 CYS A 774 CYS A 784 1555 1555 2.04 LINK OG1 THR A 209 B27 SWH A1862 1555 1555 1.64 LINK ND2 ASN A 524 C1 NAG B 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.49 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.49 LINK OD1 ASP A 171 ZN ZN A1864 1555 1555 1.95 LINK OG1 THR A 209 ZN ZN A1864 1555 1555 2.04 LINK OD1 ASP A 311 ZN ZN A1863 1555 1555 2.21 LINK NE2 HIS A 315 ZN ZN A1863 1555 1555 2.28 LINK OD2 ASP A 358 ZN ZN A1864 1555 1555 2.34 LINK NE2 HIS A 359 ZN ZN A1864 1555 1555 2.09 LINK NE2 HIS A 474 ZN ZN A1863 1555 1555 2.23 LINK OD1 ASP A 739 CA CA A1865 1555 1555 2.65 LINK OD1 ASN A 741 CA CA A1865 1555 1555 2.15 LINK OD1 ASP A 743 CA CA A1865 1555 1555 2.30 LINK O LEU A 745 CA CA A1865 1555 1555 2.43 LINK OD1 ASP A 747 CA CA A1865 1555 1555 2.16 LINK O28 SWH A1862 ZN ZN A1863 1555 1555 2.25 CISPEP 1 GLY A 69 PRO A 70 0 0.62 CISPEP 2 PRO A 70 PRO A 71 0 3.31 CISPEP 3 TYR A 205 PRO A 206 0 -1.38 CISPEP 4 GLN A 309 PRO A 310 0 1.95 CISPEP 5 ASP A 563 LEU A 564 0 -0.08 CRYST1 63.995 90.204 152.672 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015626 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011086 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006550 0.00000